FAQ on Intensity Therapeutics and Its Innovative Cancer Treatment Approach

What is Intensity Therapeutics?

Intensity Therapeutics is a late-stage clinical biotechnology company focused on discovering, developing, and commercializing first-in-class cancer drugs that directly target tumors with minimal side effects while training the patient’s immune system to fight cancer.

Who is Lew Bender?

Lew Bender is the Founder, President, and CEO of Intensity Therapeutics, with over 33 years of biotech experience in drug delivery, and he founded the company in 2012 based on a new chemistry for intratumoral injection.

What is intratumoral injection?

Intratumoral injection is a method of directly injecting drugs into tumors, differing from systemic treatments by targeting the tumor more precisely and minimizing the exposure of the rest of the body to potent drugs.

How does INT230-6 work?

INT230-6 is a formulation containing two cytotoxic agents and a dispersion enhancer that allows cancer cells to absorb these agents following direct injection into tumors, stimulating a targeted immune response.

What types of cancer is Intensity Therapeutics targeting?

Intensity Therapeutics is targeting refractory solid tumors like metastatic soft tissue sarcoma and localized triple-negative breast cancer with its lead product candidate, INT230-6.

What stage of development is INT230-6 in?

INT230-6 is in late-stage randomized controlled clinical trials, including a Phase 3 trial for refractory sarcoma and a Phase 2 study for localized triple-negative breast cancer.

Why is Intensity Therapeutics’ approach significant?

Their approach is significant because it aims to reduce the severe side effects associated with current cancer treatments by directly targeting tumors and enhancing the immune system’s ability to fight cancer, potentially improving patients’ quality of life.

Where can I find more information about Intensity Therapeutics?

More information can be found on their website at https://intensitytherapeutics.com/ or through Lew Bender’s LinkedIn profile at https://www.linkedin.com/in/lew-bender-7b5a7a7/.